Many articles in the literature attempt to explain other causes of the pathogenesis and include immunological, neural, and genetic factors, as well as metabolic syndrome, as multifactorial culprits for the lack of success of anti-VEGF therapies and the overall microvascular complications of diabetes [7,23]. This evidence concerns the gene VEGFA and diabetes mellitus.